Karani Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Karani Asset Management LLC

$69.1 Million
Q3 2023

A detailed history of Karani Asset Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Karani Asset Management LLC holds 11,555 shares of ALNY stock, worth $3.1 Million. This represents 2.96% of its overall portfolio holdings.

Number of Shares

11,555

Previous 15,245 24.2%

Holding current value

$3.1 Million

Previous $2.9 Million 29.33%

% of portfolio

2.96%

Previous 2.93%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $630,141 - $780,988	-3,690 Reduced 24.2%	11,555 $2.05 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $87,139 - $99,875	-471 Reduced 3.0%	15,245 $2.9 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $16,074 - $20,726	88 Added 0.56%	15,716 $3.15 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $841,935 - $1.1 Million	-4,538 Reduced 22.5%	15,628 $3.71 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $1.36 Million - $2.28 Million	-9,819 Reduced 32.75%	20,166 $4.04 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $839,929 - $1.18 Million	-6,975 Reduced 18.87%	29,985 $4.37 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $288,062 - $393,906	2,265 Added 6.53%	36,960 $6.04 Million
Q4 2021 Nov 23, 2022	BUY	$159.56 - $209.29 $348,798 - $457,507	2,186 Added 6.73%	34,675 $5.88 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $350,074 - $459,182	2,194 Added 6.75%	34,695 $5.88 Million
Q3 2021 Nov 23, 2022	BUY	$169.75 - $207.73 $153,114 - $187,372	902 Added 2.86%	32,489 $6.13 Million
Q3 2021 Nov 08, 2021	BUY	$169.75 - $207.73 $5.52 Million - $6.75 Million	32,501 New	32,501 $6.14 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $4.06 Million - $5.59 Million	-31,575 Closed	0 $0
Q1 2021 Nov 23, 2022	BUY	$126.83 - $175.69 $1,521 - $2,108	12 Added 0.04%	31,587 $4.46 Million
Q4 2020 Nov 23, 2022	BUY	$122.97 - $147.0 $600,708 - $718,095	4,885 Added 18.3%	31,575 $4.1 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $600,708 - $718,095	4,885 Added 18.3%	31,575 $4.1 Million
Q2 2020 Nov 23, 2022	BUY	$104.21 - $156.44 $679,866 - $1.02 Million	6,524 Added 32.35%	26,690 $3.95 Million
Q2 2020 Aug 05, 2020	BUY	$104.21 - $156.44 $2.78 Million - $4.18 Million	26,690 New	26,690 $3.95 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Karani Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karani Asset Management LLC with notifications on news.

Account

Karani Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History